sulfadiazine has been researched along with Acquired Immunodeficiency Syndrome in 83 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The preferred therapeutic regimen for Toxoplasma encephalitis (TE) is a combination of pyrimethamine and sulfadiazine, and trimethoprim-sulfamethoxazole (TMP-SMX) plus azithromycin is the widespread alternative therapeutic regimen." | 9.51 | Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial. ( Chen, H; Chen, Y; He, X; Huang, Y; Li, Y; Lu, Y; Wu, Y; Zeng, Y; Zhang, W, 2022) |
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 9.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "Sixty-five patients intolerant of conventional toxoplasmic encephalitis therapies-pyrimethamine, sulphadiazine or clindamycin-received atovaquone as maintenance therapy after resolution of an acute episode of toxoplasmic encephalitis." | 9.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "The interim results are presented of an ongoing large-scale, prospective, randomized study to determine the potential role of clindamycin in the treatment of toxoplasmic encephalitis." | 9.07 | Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Dannemann, BR; Israelski, DM; Leport, C; Luft, BJ; McCutchan, JA; Nussbaum, JN; Orellana, M; Vildé, JL, 1991) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 9.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| "Three patients with acquired immune deficiency syndrome (AIDS), central nervous system toxoplasmosis, and hypersensitivity to sulfadiazine were given treatment with clindamycin plus pyrimethamine." | 7.67 | Role of clindamycin in the treatment of central nervous system toxoplasmosis. ( Hoy, J; Rolston, KV, 1987) |
| "Thirty-five patients with the acquired immunodeficiency syndrome (AIDS) and central nervous system toxoplasmosis, seen over a 30-month period, were treated with the combination pyrimethamine/sulfadiazine." | 7.67 | Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. ( Katlama, C; Leport, C; Marche, C; Matheron, S; Raffi, F; Regnier, B; Saimot, AG; Vedrenne, C; Vilde, JL, 1988) |
| "A 45-year-old man with the Acquired Immunodeficiency Syndrome (AIDS) and CNS toxoplasmosis presented with acute renal failure, hematuria, and renal colic shortly after starting treatment with sulfadiazine." | 7.67 | Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. ( Appel, GB; Bendixen, B; Carbone, LG, 1988) |
| " Provided prophylactic and therapeutic recommendations are complied with, outcome of this drug-related side effect is usually excellent, and rare relapses will similarly respond well." | 6.39 | Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome. ( Becker, K; Häussinger, D; Jablonowski, H, 1996) |
| "Toxoplasma gondii encephalitis is an important opportunistic infection in the acquired immunodeficiency syndrome, estimated to occur in 20,000 to 40,000 patients with acquired immunodeficiency syndrome in the United States by 1991." | 6.38 | Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. ( Brosius, FC; Rothstein, DM; Simon, DI, 1990) |
| "The preferred therapeutic regimen for Toxoplasma encephalitis (TE) is a combination of pyrimethamine and sulfadiazine, and trimethoprim-sulfamethoxazole (TMP-SMX) plus azithromycin is the widespread alternative therapeutic regimen." | 5.51 | Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial. ( Chen, H; Chen, Y; He, X; Huang, Y; Li, Y; Lu, Y; Wu, Y; Zeng, Y; Zhang, W, 2022) |
| "We present here four patients with AIDS treated for toxoplasmic encephalitis who developed sulfadiazine-induced crystalluria." | 5.28 | Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. ( Belenfant, X; Doco-Lecompte, T; Idatte, JM; Modai, J; Molina, JM, 1991) |
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 5.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "Sixty-five patients intolerant of conventional toxoplasmic encephalitis therapies-pyrimethamine, sulphadiazine or clindamycin-received atovaquone as maintenance therapy after resolution of an acute episode of toxoplasmic encephalitis." | 5.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "The interim results are presented of an ongoing large-scale, prospective, randomized study to determine the potential role of clindamycin in the treatment of toxoplasmic encephalitis." | 5.07 | Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Dannemann, BR; Israelski, DM; Leport, C; Luft, BJ; McCutchan, JA; Nussbaum, JN; Orellana, M; Vildé, JL, 1991) |
| "We retrospectively examined 39 patients with AIDS and central nervous system toxoplasmosis in order to determine the efficacy and safety of two combinations: pyrimethamine-sulfadiazine and pyrimethamine-clindamycin." | 5.07 | Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS. ( Ammassari, A; Antinori, A; Camilli, G; Damiano, F; Federico, G; Maiuro, G; Pizzigallo, E; Tamburrini, E, 1992) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| "In 26 AIDS patients treated for toxoplasmic encephalitis, the inhibitory effect on Toxoxplasma growth of sequential sera taken before and after initiation of therapy was determined using a culture-based immunoassay and compared with pyrimethamine blood levels." | 3.70 | Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis. ( Derouin, F; Farinotti, R; Gérard, L; Leport, C; Maslo, C, 1998) |
| "Thirty-five patients with the acquired immunodeficiency syndrome (AIDS) and central nervous system toxoplasmosis, seen over a 30-month period, were treated with the combination pyrimethamine/sulfadiazine." | 3.67 | Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. ( Katlama, C; Leport, C; Marche, C; Matheron, S; Raffi, F; Regnier, B; Saimot, AG; Vedrenne, C; Vilde, JL, 1988) |
| "A 45-year-old man with the Acquired Immunodeficiency Syndrome (AIDS) and CNS toxoplasmosis presented with acute renal failure, hematuria, and renal colic shortly after starting treatment with sulfadiazine." | 3.67 | Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. ( Appel, GB; Bendixen, B; Carbone, LG, 1988) |
| "Three patients with acquired immune deficiency syndrome (AIDS), central nervous system toxoplasmosis, and hypersensitivity to sulfadiazine were given treatment with clindamycin plus pyrimethamine." | 3.67 | Role of clindamycin in the treatment of central nervous system toxoplasmosis. ( Hoy, J; Rolston, KV, 1987) |
| "Toxoplasmic encephalitis in AIDS patients was usually treated with sulfonamides combined with other drugs and the pooled CR was 49." | 2.52 | A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans. ( Lindsay, DS; Peng, HJ; Wei, HX; Wei, SS, 2015) |
| "We report herein the case of an AIDS patient, treated with sulfadiazine because of Nocardia pneumonia, that came to the emergency room in acute renal failure." | 2.39 | Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient. ( Chechile Toniolo, G; Fariña, LA; Palou Redorta, J, 1995) |
| " Provided prophylactic and therapeutic recommendations are complied with, outcome of this drug-related side effect is usually excellent, and rare relapses will similarly respond well." | 2.39 | Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome. ( Becker, K; Häussinger, D; Jablonowski, H, 1996) |
| " Dosage must be adjusted to the results of blood counts." | 2.38 | [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991) |
| "Toxoplasma gondii encephalitis is an important opportunistic infection in the acquired immunodeficiency syndrome, estimated to occur in 20,000 to 40,000 patients with acquired immunodeficiency syndrome in the United States by 1991." | 2.38 | Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. ( Brosius, FC; Rothstein, DM; Simon, DI, 1990) |
| "In patients with AIDS, toxoplasmosis is the most common cause of CNS mass lesions." | 2.38 | Toxoplasmosis in AIDS patients. ( Tuazon, CU, 1989) |
| "The simultaneous occurrence of cerebral toxoplasmosis and cryptococcosis is rare." | 1.91 | A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome. ( Panda, BK; Purandare, B; Rege, S; Suryawanshi, VR, 2023) |
| "A patient with AIDS, treated with highly active antiretroviral therapy and trimethoprim-sulfamethoxazole, presented with confusion, a hemifield defect, and a mass lesion in the right occipital lobe." | 1.31 | Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole. ( Conde, C; Diz, J; Gonzalez-Mediero, G; Rodriguez De Lope, A; Santiago, P; Seijo Martinez, M; Visvesvara, GS, 2000) |
| "Pneumocystis carinii prophylaxis in AIDS patients might be safety withdrawn after effective HAART." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| "The survival from AIDS or CD4 count = 50 cells/mm3 did not differ significantly between those with treated CTOX and a control group who had no toxoplasma infection, suggesting that treatment is reasonably effective." | 1.29 | Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. ( Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL, 1996) |
| "ET was the AIDS-defining condition in 44% of the patients." | 1.29 | [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients]. ( Barrio, JL; Cadafalch, J; Domingo, P; Ferrer, S; Fuentes, I; Fuster, M; Iranzo, A; Muñoz, C; Nolla, J; Ris, J; Sambeat, MA, 1996) |
| "In particular, in patients with AIDS who are more susceptible for adverse drug reactions and who are simultaneously receiving a variety of drugs with a considerable potential of cutaneous side effects, therapy cannot be withhold for lack of therapeutic alternatives." | 1.29 | [Drug-induced Stevens-Johnson syndrome in a patient with AIDS]. ( Bircher, A; Haefeli, WE; Leib, SL; Lüscher, TF; Schlienger, RG, 1993) |
| "The activity of the macrolide antibiotic clarithromycin was examined alone or in combination with other drugs for the treatment of acute or chronic infections with Toxoplasma gondii in mice." | 1.28 | Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. ( Araujo, FG; Lin, T; Prokocimer, P; Remington, JS, 1992) |
| "Pulmonary toxoplasmosis in AIDS is rare." | 1.28 | [Pulmonary toxoplasmosis in AIDS. Report of 3 cases]. ( Bouslama, K; Cabane, J; Gonzalez Canali, G; Imbert, JC; Knani, L; Lebas, J; Varette, C, 1990) |
| "We present here four patients with AIDS treated for toxoplasmic encephalitis who developed sulfadiazine-induced crystalluria." | 1.28 | Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. ( Belenfant, X; Doco-Lecompte, T; Idatte, JM; Modai, J; Molina, JM, 1991) |
| "No relapse was observed in those receiving P/S, but 40% of those treated with P/C relapsed." | 1.28 | [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]. ( Alvarez, R; Gatell, JM; González-Clemente, JM; Graus, F; Guelar, A; Jiménez de Anta, MT; Mallolas, J; Mercader, JM; Miró, JM; Pedrol, E, 1990) |
| "Drug allergy is the most common and significant allergic manifestation of HIV3 infection." | 1.28 | Allergic manifestations of human immunodeficiency virus (HIV) infection. ( Carr, A; Cooper, DA; Penny, R, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (26.51) | 18.7374 |
| 1990's | 53 (63.86) | 18.2507 |
| 2000's | 3 (3.61) | 29.6817 |
| 2010's | 2 (2.41) | 24.3611 |
| 2020's | 3 (3.61) | 2.80 |
| Authors | Studies |
|---|---|
| Suryawanshi, VR | 1 |
| Purandare, B | 1 |
| Rege, S | 1 |
| Panda, BK | 1 |
| Li, Y | 2 |
| Zeng, Y | 1 |
| Lu, Y | 1 |
| He, X | 1 |
| Wu, Y | 1 |
| Zhang, W | 1 |
| Huang, Y | 1 |
| Chen, H | 1 |
| Chen, Y | 1 |
| Zeng, YM | 1 |
| Lu, YQ | 1 |
| Qin, YY | 1 |
| Chen, YK | 1 |
| Wei, HX | 1 |
| Wei, SS | 1 |
| Lindsay, DS | 1 |
| Peng, HJ | 1 |
| Faucher, B | 1 |
| Moreau, J | 1 |
| Zaegel, O | 1 |
| Franck, J | 1 |
| Piarroux, R | 1 |
| Hill, D | 1 |
| Dubey, JP | 1 |
| Fariña, LA | 1 |
| Palou Redorta, J | 1 |
| Chechile Toniolo, G | 1 |
| Langmann, P | 1 |
| Klinker, H | 1 |
| Richter, E | 1 |
| Peh, CA | 1 |
| Kimber, TE | 1 |
| Shaw, DR | 1 |
| Clarkson, AR | 1 |
| Potter, JL | 1 |
| Kofron, WG | 1 |
| Correia, O | 1 |
| Delgado, L | 1 |
| Santos, C | 1 |
| Miranda, AM | 1 |
| Mathelier-Fusade, P | 1 |
| Leynadier, F | 1 |
| Ajisawa, A | 1 |
| Rivera, M | 1 |
| Liano, F | 1 |
| Fortún, J | 2 |
| Fernández-Lucas, M | 1 |
| Ortuno, J | 1 |
| Schlienger, RG | 1 |
| Haefeli, WE | 1 |
| Bircher, A | 1 |
| Leib, SL | 1 |
| Lüscher, TF | 1 |
| Ragnaud, JM | 1 |
| Morlat, P | 3 |
| Dupon, M | 1 |
| Lacoste, D | 1 |
| Pellegrin, JL | 1 |
| Chene, G | 1 |
| Murray-Pulsifer, K | 1 |
| Ferrer, S | 1 |
| Fuentes, I | 1 |
| Domingo, P | 1 |
| Muñoz, C | 1 |
| Iranzo, A | 1 |
| Barrio, JL | 1 |
| Fuster, M | 1 |
| Ris, J | 1 |
| Sambeat, MA | 1 |
| Cadafalch, J | 1 |
| Nolla, J | 1 |
| Becker, K | 1 |
| Jablonowski, H | 1 |
| Häussinger, D | 1 |
| Wei, ME | 1 |
| Campbell, SH | 1 |
| Taylor, C | 1 |
| Moreno García, M | 1 |
| Fernández González, F | 1 |
| Fernández Rodríguez, E | 1 |
| Portús de Marco, MV | 1 |
| Katlama, C | 4 |
| Mouthon, B | 1 |
| Gourdon, D | 1 |
| Lapierre, D | 1 |
| Rousseau, F | 1 |
| Laing, RB | 1 |
| Flegg, PJ | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Burns, SM | 1 |
| Ebrahimzadeh, A | 1 |
| Bottone, EJ | 1 |
| de Luis, DA | 1 |
| Pintado, V | 1 |
| Aller de la Fuente, R | 1 |
| Derouin, F | 2 |
| Gérard, L | 1 |
| Farinotti, R | 1 |
| Maslo, C | 3 |
| Leport, C | 10 |
| Carrión-Carrión, C | 1 |
| Morales-Suárez-Varela, MM | 1 |
| Llopis-González, A | 1 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| Seijo Martinez, M | 1 |
| Gonzalez-Mediero, G | 1 |
| Santiago, P | 1 |
| Rodriguez De Lope, A | 1 |
| Diz, J | 1 |
| Conde, C | 1 |
| Visvesvara, GS | 1 |
| Chirgwin, K | 1 |
| Hafner, R | 2 |
| Remington, J | 1 |
| Andersen, J | 1 |
| Bosler, EM | 1 |
| Roque, C | 1 |
| Rajicic, N | 1 |
| McAuliffe, V | 1 |
| Jayaweera, DT | 1 |
| Vilde, JL | 6 |
| Luft, BJ | 4 |
| Antinori, A | 1 |
| Ammassari, A | 1 |
| Maiuro, G | 1 |
| Camilli, G | 1 |
| Damiano, F | 1 |
| Federico, G | 1 |
| Pizzigallo, E | 1 |
| Tamburrini, E | 1 |
| Marques, LP | 1 |
| Silva, MT | 1 |
| Madeira, EP | 1 |
| Santos, OR | 1 |
| Araujo, FG | 1 |
| Prokocimer, P | 1 |
| Lin, T | 1 |
| Remington, JS | 3 |
| Reboli, AC | 1 |
| Mandler, HD | 1 |
| De Jaureguiberry, JP | 1 |
| Reboul, P | 1 |
| Vey, N | 1 |
| Jaubert, D | 1 |
| Longuet, P | 1 |
| Iannucci, AA | 1 |
| Hart, LL | 1 |
| Corbella, X | 1 |
| Mascaró, J | 1 |
| Santín, M | 1 |
| Carratalà, J | 1 |
| Carr, A | 1 |
| Cooper, DA | 2 |
| Penny, R | 2 |
| Dannemann, B | 1 |
| McCutchan, JA | 2 |
| Israelski, D | 1 |
| Antoniskis, D | 2 |
| Luft, B | 1 |
| Nussbaum, J | 1 |
| Clumeck, N | 1 |
| Chiu, J | 2 |
| de Gans, J | 1 |
| Portegies, P | 1 |
| Reiss, P | 1 |
| Troost, D | 1 |
| van Gool, T | 1 |
| Lange, JM | 1 |
| Fégueux, S | 2 |
| De Truchis, P | 2 |
| Balloul, H | 2 |
| Matheron, S | 4 |
| Coulaud, JP | 2 |
| Niyongabo, T | 2 |
| Molina, JM | 1 |
| Belenfant, X | 1 |
| Doco-Lecompte, T | 1 |
| Idatte, JM | 1 |
| Modai, J | 1 |
| Díaz Benito, JA | 1 |
| Rodríguez García, JC | 1 |
| Piñeiro Gómez-Durán, L | 1 |
| Tenant-Flowers, M | 1 |
| Boyle, MJ | 1 |
| Carey, D | 1 |
| Marriott, DJ | 1 |
| Harkness, JL | 1 |
| Tournerie, C | 1 |
| Raguin, G | 1 |
| Fernandez-Martin, J | 1 |
| Dannemann, BR | 1 |
| Israelski, DM | 1 |
| Nussbaum, JN | 1 |
| Orellana, M | 1 |
| de la Hoz Caballer, B | 1 |
| Fernandez-Rivas, M | 1 |
| Fraj Lazaro, J | 1 |
| Quirce Gancedo, S | 1 |
| Davila Ruiz, I | 1 |
| Puyana Ruiz, J | 1 |
| Cuesta Herranz, J | 1 |
| Alvarez Cuesta, E | 1 |
| Cuevas, M | 1 |
| Perez Elias, MJ | 1 |
| González-Clemente, JM | 2 |
| Miró, JM | 2 |
| Pedrol, E | 2 |
| Alvarez, R | 2 |
| Gatell, JM | 2 |
| Mallolas, J | 2 |
| Graus, F | 2 |
| Mercader, JM | 2 |
| Guelar, A | 1 |
| Jiménez de Anta, MT | 2 |
| Simon, DI | 1 |
| Brosius, FC | 1 |
| Rothstein, DM | 1 |
| Knani, L | 1 |
| Bouslama, K | 1 |
| Varette, C | 1 |
| Gonzalez Canali, G | 1 |
| Cabane, J | 1 |
| Lebas, J | 1 |
| Imbert, JC | 1 |
| Chakroun, M | 1 |
| Meyohas, MC | 1 |
| Pelosse, B | 1 |
| Zazoun, L | 1 |
| Vacherot, B | 1 |
| Christin, S | 1 |
| Baumelou, A | 1 |
| Bahri, S | 1 |
| Ben Hmida, M | 1 |
| Deray, G | 1 |
| Jacobs, C | 1 |
| Mitchell, CD | 1 |
| Erlich, SS | 1 |
| Mastrucci, MT | 1 |
| Hutto, SC | 1 |
| Parks, WP | 1 |
| Scott, GB | 1 |
| Berenguer, J | 1 |
| Carrazana, EJ | 1 |
| Rossitch, E | 1 |
| Samuels, MA | 1 |
| Altés, J | 1 |
| Salas, A | 1 |
| Ricart, C | 1 |
| Villalonga, C | 1 |
| Riera, M | 1 |
| Casquero, P | 1 |
| Gilman, TM | 1 |
| Boylen, CT | 1 |
| Sattler, FR | 1 |
| Tuazon, CU | 3 |
| Cohn, JA | 1 |
| McMeeking, A | 1 |
| Cohen, W | 1 |
| Jacobs, J | 1 |
| Holzman, RS | 1 |
| Ventura, MG | 1 |
| Wybran, J | 1 |
| Farber, CM | 1 |
| Bell, ET | 1 |
| Tapper, ML | 1 |
| Pollock, AA | 1 |
| Allegra, CJ | 1 |
| Chabner, BA | 1 |
| Ogata-Arakaki, D | 1 |
| Baird, B | 1 |
| Drake, JC | 1 |
| Simmons, JT | 1 |
| Lack, EE | 1 |
| Shelhamer, JH | 1 |
| Balis, F | 1 |
| Kovacs, JA | 1 |
| Masur, H | 1 |
| Gilquin, J | 1 |
| Magar, Y | 1 |
| Acar, JF | 1 |
| Blamoutier, J | 1 |
| Bonaventura, I | 1 |
| Romero, F | 1 |
| Ortega, A | 1 |
| Navarro, C | 1 |
| Juste, C | 1 |
| Codina Puiggrós, A | 1 |
| Raffi, F | 1 |
| Regnier, B | 2 |
| Saimot, AG | 2 |
| Marche, C | 1 |
| Vedrenne, C | 1 |
| Carbone, LG | 1 |
| Bendixen, B | 1 |
| Appel, GB | 1 |
| Sahai, J | 1 |
| Heimberger, T | 1 |
| Collins, K | 1 |
| Kaplowitz, L | 1 |
| Polk, R | 1 |
| Wanke, C | 1 |
| Kovacs, A | 1 |
| Dina, T | 1 |
| Davis, DO | 1 |
| Barton, N | 1 |
| Katz, D | 1 |
| Lunde, M | 1 |
| Levy, C | 1 |
| Conley, FK | 1 |
| Rolston, KV | 1 |
| Hoy, J | 1 |
| Goadsby, PJ | 1 |
| Donaghy, AJ | 1 |
| Lloyd, AR | 1 |
| Wakefield, D | 1 |
| Reinert, P | 1 |
| Bernaudin, F | 1 |
| Ledford, DK | 1 |
| Overman, MD | 1 |
| Gonzalvo, A | 1 |
| Cali, A | 1 |
| Mester, SW | 1 |
| Lockey, RF | 1 |
| Catterall, JR | 1 |
| Potasman, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis[NCT00000794] | Phase 2 | 100 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for sulfadiazine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Antiprotozoal Agents; Azithromycin; Clind | 2015 |
Toxoplasma gondii: transmission, diagnosis and prevention.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Protozoan; Cats; Cattle; Deer; Encephalitis | 2002 |
Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infection | 1995 |
[Intolerance to sulfonamides in HIV infected subjects. Toxic and allergic origin].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Drug Eruptions; Humans; P | 1993 |
Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Age | 1996 |
[Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; | 1992 |
Clindamycin in the treatment of toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Humans; Pyrimethamine; Retrospective Studies; Sulfa | 1992 |
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum | 1991 |
Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Crystallization; Drug Therapy, Combi | 1990 |
Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Pneumonia, Pneumocys | 1989 |
Toxoplasmosis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Mice; Opportunistic | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, | 1988 |
AIDS commentary. Toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Antibodies, Protozoan; Antimetab | 1988 |
9 trials available for sulfadiazine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clindamycin; Encephalitis; Humans; Sulfadiazine; S | 2022 |
A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-I | 2020 |
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalit | 1996 |
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Ani | 2002 |
Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Clindamycin; Drug Combinations; | 1992 |
Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clindamycin; Drug Evaluation; Drug Therapy, Combination; | 1992 |
Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Humans; Op | 1991 |
Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Humans; In | 1991 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug C | 1985 |
61 other studies available for sulfadiazine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococ | 2023 |
Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiprotozoal Agents; CD4 Lymphocyte Cou | 2011 |
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Resistance; Drug Therapy, Combination; Humans; Pyr | 1995 |
Acute renal failure due to sulphadiazine in a patient with acquired immunodeficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infection | 1995 |
Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Hemophilia A; Huma | 1994 |
HIV-1 in blister fluid of a patient with toxic epidermal necrolysis and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biomarkers; Blister; Exudates and Transudates; Female; HI | 1994 |
[Protozoan infections in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; AIDS-Related Opportunistic Infection | 1993 |
Sulfadiazine-induced obstructive renal failure in a patient with acquired immunodeficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Humans; Kidney Failure, Chronic; Male; Middle Aged; Sulfadiazine | 1993 |
[Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Phenytoin; Pyrimethamine; Stevens-Joh | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Cl | 1993 |
From the Centers for Disease Control and Prevention. Availability of sulfadiazine--United States.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Infant, Newborn; Sulfadiazine; Sulfam | 1993 |
Two central nervous system infectious diseases in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Hu | 1993 |
[Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clind | 1996 |
Precipitous visual loss secondary to optic nerve toxoplasmosis as an unusual presentation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therap | 1996 |
[Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Anti-Infective Agents; Antiviral Agents; Cefta | 1996 |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal | 1996 |
Persistent diarrhea caused by Isospora belli: therapeutic response to pyrimethamine and sulfadiazine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Antitrichomonal Agents; Diarrhea | 1996 |
[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory | 1997 |
Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dr | 1998 |
Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Fatal Outcome; Humans; Male; Steven | 1999 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole.
Topics: Acanthamoeba; Acquired Immunodeficiency Syndrome; Adult; Amebiasis; Animals; Antibiotic Prophylaxis; | 2000 |
Obstructive renal failure due to therapy with sulfadiazine in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Female; Humans; Sulfadiazine | 1992 |
Availability of sulfadiazine--United States.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Infant, Newborn; Sulfadiazine; Sulfam | 1992 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarith | 1992 |
Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Psychoses, Substance-Induced; Sulfadiazine; | 1992 |
[Acute renal failure caused by sulfadiazine crystalluria in AIDS. An historical resurgent iatrogenic complication].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Humans; Iatrogenic Disease; Male; Op | 1992 |
[Acute kidney failure due to sulfadiazine in the treatment of cerebral toxoplasmosis].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; HIV-1; Humans; Male; Middle Aged; Opportuni | 1992 |
Allergic manifestations of human immunodeficiency virus (HIV) infection.
Topics: Acquired Immunodeficiency Syndrome; Drug Hypersensitivity; Ganglionic Blockers; Humans; Immunoglobul | 1991 |
Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Therapy, Combination; Female; Humans; Male; Opportun | 1992 |
Sulphadiazine desensitization in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Desensitization, Immunologic; Female; Humans; Male; Sulfadiazine | 1991 |
Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Crystallization; Encephalitis; Femal | 1991 |
[Cerebral toxoplasmosis as a cause of treatable dementia in an aged patient].
Topics: Acquired Immunodeficiency Syndrome; Aged; Brain; Brain Diseases; Dementia; Humans; Male; Pyrimethami | 1991 |
Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Brain Edema; Desensitization, Immun | 1991 |
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Follow-Up | 1991 |
Management of sulfadiazine allergy in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Desensitization, Immunologic; Dose-Respons | 1991 |
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Biopsy; Brain; Brain Diseases; Clindamycin; Drug | 1990 |
[The re-introduction of sulfadiazine in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Drug Hypersensitivity; Drug Tolerance; Female; H | 1990 |
[Pulmonary toxoplasmosis in AIDS. Report of 3 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; | 1990 |
[Ocular toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Humans; Male; Middle Aged; Opportunistic | 1990 |
Acute renal failure due to sulfadiazine in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Crystallization; Female; Humans; Mal | 1990 |
Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Topics: Acquired Immunodeficiency Syndrome; Animals; Central Nervous System Diseases; Family Health; Female; | 1990 |
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Clindamycin; Drug Combinations; | 1990 |
Toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Encephalitis; Humans; Opportunistic Infection | 1990 |
Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Encephalitis; Female; Humans; Male; Middle Aged; Py | 1989 |
[Cerebral toxoplasmosis in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Drug Evaluation; Drug Therapy, Combinatio | 1989 |
Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Brain; Clindamycin; Encephalitis; Female; Humans; | 1989 |
Sulfadiazine revisited.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Brain Diseases; Crystallization; D | 1989 |
Sulphadiazine desensitisation in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Desensitization, Immunologic; Humans; Male; Sulf | 1985 |
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Evaluation; Drug Therapy, Combination; Female; Folic | 1987 |
[Induction of tolerance to sulfadiazine in a patient with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Drug Tolerance; Humans; Male; Sulfadiazin | 1988 |
[Cerebral toxoplasmosis in the acquired immunodeficiency syndrome. Study of the clinical, radiological, and pathological findings in 10 cases].
Topics: Acquired Immunodeficiency Syndrome; Brain Abscess; Brain Diseases; Humans; Opportunistic Infections; | 1988 |
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Drug Therapy, Combinatio | 1988 |
Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Brain Diseases; Crystallization; Hum | 1988 |
Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder.
Topics: Acquired Immunodeficiency Syndrome; Crystallization; Humans; Male; Middle Aged; Sulfadiazine; Toxopl | 1988 |
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies; Drug Therapy, Combination; Encephalitis; Huma | 1987 |
[Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Drug Combinations; Female; Humans; Leucom | 1987 |
Role of clindamycin in the treatment of central nervous system toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Clindamycin; Drug Therap | 1987 |
Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Crystallization; Humans; Male; Sulfa | 1987 |
[Opportunistic Toxoplasma gondii infections].
Topics: Acquired Immunodeficiency Syndrome; Child, Preschool; Drug Combinations; Humans; Immunologic Deficie | 1985 |
Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Apicomplexa; Drug Therapy, Combination; Humans; Male; Mus | 1985 |